Thr405

Site Information
AMBIGUOUS SITES: ognl.NoConversionPossible:
RLWGKLQtQGLGTAL SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 15403310

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 )
Disease tissue studied:	gastric cancer ( 2 ) , gastric carcinoma ( 2 ) , acute erythroid leukemias, including erythroleukemia (M6a) and very rare pure erythroid leukemia (M6b) ( 1 ) , acute megakaryoblastic leukemia (M7) ( 1 ) , acute monoblastic leukemia (M5a) or acute monocytic leukemia (M5b) ( 1 ) , acute myeloblastic leukemia, with granulocytic maturation (M2) ( 1 )
Relevant cell line - cell type - tissue:	AML-193 (monocyte) ( 1 ) , CMK (megakaryoblast) ( 1 ) , HEL (erythroid) ( 1 ) , Kasumi-1 (myeloid) ( 1 ) , KG-1 (myeloid) ( 1 ) , MKN-45 (gastric) ( 2 ) , MV4-11 (macrophage) ( 1 ) , P31/FUJ (erythroid) ( 1 )

References
1	Casado P, et al. (2013) Phosphoproteomics data classify hematological cancer cell lines according to tumor type and sensitivity to kinase inhibitors. Genome Biol 14, R37 23628362 Curated Info
2	Possemato A (2010) CST Curation Set: 9174; Year: 2010; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Curated Info